Please use this identifier to cite or link to this item:
|dc.title||Small interfering RNA-mediated silencing of cytochrome P450 3A4 gene|
|dc.identifier.citation||Chen, J., Yang, X.-X., Huang, M., Hu, Z.-P., He, M., Duan, W., Chan, E., Sheu, F.-S., Chen, X., Zhou, S.-F. (2006). Small interfering RNA-mediated silencing of cytochrome P450 3A4 gene. Drug Metabolism and Disposition 34 (9) : 1650-1657. ScholarBank@NUS Repository. https://doi.org/10.1124/dmd.106.009837|
|dc.description.abstract||RNA interference (RNAi) is a specific and powerful tool used to manipulate gene expression and study gene function. The cytochrome P450 3A4 (CYP3A4) can metabolize more than 50% of drugs. In the present study, we investigated whether vector-expressed small interfering RNAs (siRNAs) altered the CYP3A4 expression and function using the Chinese hamster cell line (V79) overexpressing CYP3A4 (CHL-3A4). Three different siRNA oligonucleotides (3A4I, 3A4II, and 3A4III) were designed and tested for their ability to interfere with CYP3A4 gene expression. Our study demonstrated that transient transfection of CHL-3A4 cells with the 3A4III siRNAs, but not 3A4I and II, significantly reduced CYP3A4 mRNA levels by 65% and protein expression levels by 75%. All these siRNAs did not affect the expression of CYP3A5 at both mRNA and protein levels in V79 cells overexpressing CYP3A5. Transfection of CHL-3A4 cells with 3A4III siRNAs significantly diminished the cytotoxicity of two CYP3A4 substrate drugs, cyclophosphamide and ifosfamide, in CHL-3A4 cells, with the IC50 increased from 55 to 210 μM to >1000 μM. Nifedipine at 5.78, 14.44, and 28.88 μM was significantly (P < 0.01) depleted by approximately 100, 40, and 22%, respectively, in S9 fractions from CHL-3A4 cells compared with parental CHL-pIC19h cells. In addition, transfection of the CHL-3A4 cells with vectors expressing the 3A4III siRNAs almost completely inhibited CYP3A4-mediated nifedipine metabolism. This study demonstrated, for the first time, the specific suppression of CYP3A4 expression and function using vector-based RNAi technique. The use of RNAi is a promising tool for the study of cytochrome P450 family function. Copyright © 2006 by The American Society for Pharmacology and Experimental Therapeutics.|
|dc.description.sourcetitle||Drug Metabolism and Disposition|
|Appears in Collections:||Staff Publications|
Show simple item record
Files in This Item:
There are no files associated with this item.
checked on Apr 4, 2020
WEB OF SCIENCETM
checked on Mar 18, 2020
checked on Mar 28, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.